ОПРЕДЕЛЕНИЕ ПОКАЗАНИЙ К ПРОВЕДЕНИЮ РЕСИНХРОНИЗИРУЮЩЕЙ ТЕРАПИИ С ПОМОЩЬЮ 3D-ЭХОКАРДИОГРАФИИ

To assess the diagnostic value to the live three-dimensional echocardiography (Live 3D Echo) for the revelation of indications to the cardiac resynchronization therapy and the control of its effectiveness, 18 patients aged 48-60 years (mean 55.2±5.3 years) with dilated or hypertrophic cardiomyopathy accompanied by chronic heart failure of III-IV functional classes according to the NYHA classification were examined.